New Data Lead to Decision to Revoke Autoimmune Disease Drug

The EMA says the benefits of Tavneos no longer outweigh the risks for the treatment of active granulomatosis with polyangiitis.
Medscape News Europe

Source link : https://www.medscape.com/viewarticle/new-data-lead-decision-revoke-autoimmune-disease-drug-2026a1000lut?src=rss

Author :

Publish date : 2026-06-26 16:15:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

New Data Lead to Decision to Revoke Autoimmune Disease Drug

Carcinogen Concerns Trigger Review of Rifadin Syrup

Huntington’s Therapy Rides Regulatory Roller Coaster

Related Posts

What Journal Retracted a Hyped Cancer Study?

Scream, It’s Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

AI Smart Glasses Show Promise, Limitations as Aid for Patients With Low Vision

New Parkinson’s Drug Combines Immediate and Slow Release

Huntington’s Therapy Rides Regulatory Roller Coaster

Carcinogen Concerns Trigger Review of Rifadin Syrup

What Journal Retracted a Hyped Cancer Study?

Scream, It’s Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

AI Smart Glasses Show Promise, Limitations as Aid for Patients With Low Vision

New Parkinson’s Drug Combines Immediate and Slow Release

Huntington’s Therapy Rides Regulatory Roller Coaster

New Data Lead to Decision to Revoke Autoimmune Disease Drug

Carcinogen Concerns Trigger Review of Rifadin Syrup

I have a 100 per cent chance of getting cancer due to a rare gene

Categories

Archives